We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Improve your screening know-how with TTP LabTech at Screening Europe 2010

Read time: Less than a minute

On 11th February, TTP LabTech will be offering a free workshop entitled “The Identification of novel cancer targets using a rapid, high-content, genome wide RNAi screen”. Based on the Acumen platform, this workshop will describe how information identifying high quality hits can be accessed quickly and easily either by in-house data generation or via an outsourced service.

In addition, Gaetan Touyer, Head of Screening Group, Vitry Research Center at Sanofi Aventis will present a study of five screening assays, including cell-based protein-protein interaction, homogeneous cell receptor ligand binding and cell cycle analysis at 11.45am on the 12th February. The talk explores his experiences of integrating the Acumen eX3 microplate cytometer into an HTS platform to achieve a screening throughput of tens of thousands of wells per day using a complex yet controlled process with multiple experimental steps.

Visitors to the TTP LabTech stand #12, will also be able to find out more about the new high content screening service now on offer. Based on the industry-proven Acumen platform, this service offers a highly flexible approach to cell-based screening, providing high-throughput, content-rich and highly multiplexed data for applications such as target identification, primary screening and preclinical toxicology.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.